Literature DB >> 17899321

Anabolic effect of beta-cryptoxanthin in osteoblastic MC3T3-E1 cells is enhanced with 17beta-estradiol, genistein, or zinc sulfate in vitro: the unique effect with zinc on Runx2 and alpha1(I) collagen mRNA expressions.

Satoshi Uchiyama1, Masayoshi Yamaguchi.   

Abstract

Whether the anabolic effect of beta-cryptoxanthin (CRP), a kind of carotenoid, on osteoblastic MC3T3-E1 cells are modulated in the presence of various hormones or nutrient factors were investigated. Cells were cultured for 72 h in a minimum essential medium containing 10% fetal bovine serum (FBS), and the cells with subconfluency were changed to a medium containing either vehicle or CRP (10(-8)-10(-6) M) in the presence or absence of various factors without FBS. Cells were cultured for 72 h. Protein content or alkaline phosphatase activity in osteoblastic cells were significantly increased after culture with CRP (10(-7) or 10(-6) M), 1,25-dihydroxyvitamin D(3) (VD(3); 10(-9) or 10(-8) M), 17beta-estradiol (E(2); 10(-9) M), genistein (10(-7) or 10(-6) M), or menaquinone-7 (MK-7; 10(-7) or 10(-6) M). The effect of CRP (10(-6) M) in increasing protein content in the cells was significantly enhanced in the presence of E(2) (10(-9) M) or genistein (10(-6) M). Gene expression in osteoblastic cells was determined using reverse transcription-polymerase chain reaction (RT-PCR). Culture with CRP (10(-7) or 10(-6) M) caused a significant increase in the expression of Runx2 and alkaline phosphatase mRNAs in the cells. Runx2 mRNA expression was significantly increased after culture with E(2) (10(-9) M) or MK-7 (10(-7) or 10(-6) M), but not VD(3) (10(-9) or 10(-8) M) or genistein (10(-7) or 10(-6) M). Alkaline phosphatase mRNA expression was significantly increased after culture with VD(3) (10(-9) or 10(-8) M), genistein (10(-7) or 10(-6) M), or MK-7 (10(-7) or 10(-6) M), but not E(2) (10(-10) or 10(-9) M). The effect of CRP (10(-7) or 10(-6) M) in increasing Runx2 or alkaline phosphatase mRNA expressions in the cells was not enhanced in the presence of VD(3), E(2), genistein, or MK-7. Culture with zinc sulfate (zinc; 10(-5) M) caused a significant increase in protein content or alkaline phosphatase activity in osteoblastic cells. The effect of CRP (10(-7) M) in increasing protein content or alkaline phosphatase activity in the cells was not significantly enhanced in the presence of zinc (10(-5) M). Culture with zinc (10(-5) M) caused a significant increase in alpha1(I) collagen mRNA expression, while it did not have a significant effect on Runx2 or osteocalcin mRNA expressions in the cells. The effect of CRP (10(-7) M) in increasing Runx2 or alpha1(I) collagen mRNA expressions was significantly enhanced in the presence of zinc (10(-6 )or 10(-5) M). Such an effect was not seen in the presence of cycloheximide (10(-7) M), an inhibitor of protein synthesis, or 5,6-dichloro-1-beta-D: -ribofuranosyl-benzimidazole (DRB; 10(-6) M), an inhibitor of transcriptional activity. This study demonstrates that the stimulatory effect of CRP on protein content in osteoblastic cells was additively enhanced with E(2) or genistein, and that the stimulatory effect of CRP on Runx2 or alpha1(I) collagen mRNA expressions was enhanced in the presence of zinc. Thus, the anabolic effect of CRP in osteoblastic MC3T3-E1 cells was modulated with a specific factor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17899321     DOI: 10.1007/s11010-007-9600-9

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  28 in total

1.  Oral administration of beta-cryptoxanthin prevents bone loss in ovariectomized rats.

Authors:  Satoshi Uchiyama; Masayoshi Yamaguchi
Journal:  Int J Mol Med       Date:  2006-01       Impact factor: 4.101

2.  Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts.

Authors:  T Komori; H Yagi; S Nomura; A Yamaguchi; K Sasaki; K Deguchi; Y Shimizu; R T Bronson; Y H Gao; M Inada; M Sato; R Okamoto; Y Kitamura; S Yoshiki; T Kishimoto
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

3.  Histomorphological confirmation of the preventive effect of beta-alanyl-L-histidinato zinc on bone loss in ovariectomized rats.

Authors:  S Kishi; Y Segawa; M Yamaguchi
Journal:  Biol Pharm Bull       Date:  1994-06       Impact factor: 2.233

4.  beta-Cryptoxanthin stimulates cell proliferation and transcriptional activity in osteoblastic MC3T3-E1 cells.

Authors:  Satoshi Uchiyama; Masayoshi Yamaguchi
Journal:  Int J Mol Med       Date:  2005-04       Impact factor: 4.101

5.  Effect of zinc-chelating dipeptides on osteoblastic MC3T3-E1 cells: activation of aminoacyl-tRNA synthetase.

Authors:  M Yamaguchi; S Kishi; M Hashizume
Journal:  Peptides       Date:  1994       Impact factor: 3.750

6.  Effect of carotenoid on calcium content and alkaline phosphatase activity in rat femoral tissues in vitro: the unique anabolic effect of beta-cryptoxanthin.

Authors:  Masayoshi Yamaguchi; Satoshi Uchiyama
Journal:  Biol Pharm Bull       Date:  2003-08       Impact factor: 2.233

7.  Stimulatory effect of zinc on bone formation in tissue culture.

Authors:  M Yamaguchi; H Oishi; Y Suketa
Journal:  Biochem Pharmacol       Date:  1987-11-15       Impact factor: 5.858

8.  Studies on the structure of the mouse CBF-A gene and properties of a truncated CBF-A isoform generated from an alternatively spliced RNA.

Authors:  K Y Sohn; S N Maity; B de Crombrugghe
Journal:  Gene       Date:  1994-02-25       Impact factor: 3.688

9.  Oral administration in combination with zinc enhances beta-cryptoxanthin-induced anabolic effects on bone components in the femoral tissues of rats in vivo.

Authors:  Masayoshi Yamaguchi; Satoshi Uchiyama; Kaori Ishiyama; Ken Hashimoto
Journal:  Biol Pharm Bull       Date:  2006-02       Impact factor: 2.233

10.  beta-Cryptoxanthin stimulates bone formation and inhibits bone resorption in tissue culture in vitro.

Authors:  Masayoshi Yamaguchi; Satoshi Uchiyama
Journal:  Mol Cell Biochem       Date:  2004-03       Impact factor: 3.396

View more
  6 in total

1.  Zinc stimulates osteoblastogenesis and suppresses osteoclastogenesis by antagonizing NF-κB activation.

Authors:  Masayoshi Yamaguchi; M Neale Weitzmann
Journal:  Mol Cell Biochem       Date:  2011-05-01       Impact factor: 3.396

Review 2.  Role of carotenoid β-cryptoxanthin in bone homeostasis.

Authors:  Masayoshi Yamaguchi
Journal:  J Biomed Sci       Date:  2012-04-02       Impact factor: 8.410

3.  Protection against T1DM-Induced Bone Loss by Zinc Supplementation: Biomechanical, Histomorphometric, and Molecular Analyses in STZ-Induced Diabetic Rats.

Authors:  Raul Hernandes Bortolin; Bento João da Graça Azevedo Abreu; Marcela Abbott Galvão Ururahy; Karla Simone Costa de Souza; João Felipe Bezerra; Melina Bezerra Loureiro; Flávio Santos da Silva; Dáfiny Emanuele da Silva Marques; Angélica Amanda de Sousa Batista; Gisele Oliveira; André Ducati Luchessi; Valéria Morgiana Gualberto Duarte Moreira Lima; Carlos Eduardo Saraiva Miranda; Marcus Vinicius Lia Fook; Maria das Graças Almeida; Luciana Augusto de Rezende; Adriana Augusto de Rezende
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

4.  Combined Effects of Soy Isoflavones and β-Carotene on Osteoblast Differentiation.

Authors:  Yoriko Nishide; Yuko Tousen; Miki Tadaishi; Masaki Inada; Chisato Miyaura; Marlena C Kruger; Yoshiko Ishimi
Journal:  Int J Environ Res Public Health       Date:  2015-10-28       Impact factor: 3.390

5.  Association between Dietary Carotenoid Intake and Bone Mineral Density in Korean Adults Aged 30-75 Years Using Data from the Fourth and Fifth Korean National Health and Nutrition Examination Surveys (2008-2011).

Authors:  Gebereamanuel Meron Regu; Hyesook Kim; You Jin Kim; Ju Eun Paek; Gunjeong Lee; Namsoo Chang; Oran Kwon
Journal:  Nutrients       Date:  2017-09-16       Impact factor: 5.717

Review 6.  Relationship between Structure and Biological Activity of Various Vitamin K Forms.

Authors:  Katarzyna Bus; Arkadiusz Szterk
Journal:  Foods       Date:  2021-12-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.